Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
TG Therapeutics
TGTX
$9.8B
| $135M | 0.03% |
2,423,794
+1,465,946
| +153% | +$79.3M |
2013 Q2
53 quarters
|
|
402
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.7B
| $135M | 0.03% |
1,750,001
+500,000
| +40% | +$39.2M |
2022 Q1
18 quarters
|
|
403
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$44.2B
| $135M | 0.03% |
1,511,900
+1,411,900
| +1,412% | +$131M |
2025 Q3
4 quarters
|
|
404
Coherent
COHR
$42.3B
| $135M | 0.03% |
469,020
+103,560
| +28% | +$31.1M |
2013 Q2
53 quarters
|
|
405
Nu Holdings
NU
$58.4B
| $135M | 0.03% |
10,650,794
+732,293
| +7% | +$10.4M |
2022 Q1
18 quarters
|
|
406
CALL
UnitedHealth
UNH
$363B
| $134M | 0.03% |
366,200
+63,600
| +21% | +$25.6M |
2023 Q4
11 quarters
|
|
407
PUT
Amgen
AMGN
$252B
| $133M | 0.03% |
314,600
+229,200
| +268% | +$91.4M |
2024 Q3
8 quarters
|
|
408
Yum China
YUMC
$16.7B
| $132M | 0.03% |
3,222,107
-432,409
| -12% | -$19.2M |
2016 Q4
39 quarters
|
|
409
Agnico Eagle Mines
AEM
$96.3B
| $132M | 0.03% |
722,471
+311,939
| +76% | +$55.3M |
2013 Q2
53 quarters
|
|
410
CALL
Alibaba
BABA
$256B
| $132M | 0.03% |
1,230,900
-33,000
| -3% | -$3.81M |
2014 Q3
48 quarters
|
|
411
Truist Financial
TFC
$60.2B
| $132M | 0.03% |
2,853,296
-151,366
| -5% | -$7.69M |
2022 Q1
18 quarters
|
|
412
EOG Resources
EOG
$78.6B
| $131M | 0.03% |
952,139
-680,858
| -42% | -$97.1M |
2013 Q2
53 quarters
|
|
413
IAMGOLD
IAG
$10.5B
| $131M | 0.03% |
7,095,813
+1,629,488
| +30% | +$29.1M |
2013 Q2
53 quarters
|
|
414
Novo Nordisk
NVO
$179B
| $130M | 0.03% |
3,428,026
+688,409
| +25% | +$31.7M |
2016 Q1
42 quarters
|
|
415
PUT
Wells Fargo
WFC
$257B
| $130M | 0.03% |
1,619,200
+654,000
| +68% | +$56.6M |
2024 Q3
8 quarters
|
|
416
Illinois Tool Works
ITW
$81.9B
| $129M | 0.03% |
501,124
-60,361
| -11% | -$16.8M |
2013 Q2
53 quarters
|
|
417
Allstate
ALL
$64.6B
| $129M | 0.03% |
579,762
+69,709
| +14% | +$17.7M |
2013 Q2
53 quarters
|
|
418
Pinduoduo
PDD
$113B
| $128M | 0.03% |
1,644,145
-118,443
| -7% | -$10M |
2019 Q1
30 quarters
|
|
419
United Airlines
UAL
$39.2B
| $128M | 0.03% |
1,154,215
+305,062
| +36% | +$36M |
2013 Q2
53 quarters
|
|
420
Albemarle
ALB
$11.2B
| $128M | 0.03% |
1,210,184
-2,086,367
| -63% | -$259M |
2013 Q2
53 quarters
|
|
421
Targa Resources
TRGP
$60.4B
| $128M | 0.03% |
472,715
-252,118
| -35% | -$70.6M |
2013 Q2
53 quarters
|
|
422
Cencora
COR
$66.5B
| $128M | 0.03% |
425,370
+147,394
| +53% | +$46.3M |
2013 Q2
53 quarters
|
|
423
Energy Transfer Partners
ET
$66.9B
| $127M | 0.03% |
6,420,677
-731,497
| -10% | -$15.1M |
2013 Q2
53 quarters
|
|
424
CALL
Palo Alto Networks
PANW
$267B
| $126M | 0.03% |
318,000
+192,800
| +154% | +$68.6M |
2025 Q2
5 quarters
|
|
425
Moderna
MRNA
$101B
| $126M | 0.03% |
655,783
-379,343
| -37% | -$40.9M |
2019 Q1
30 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.